CN115819494A - 用于蛋白质聚乙二醇化的添加剂体系 - Google Patents

用于蛋白质聚乙二醇化的添加剂体系 Download PDF

Info

Publication number
CN115819494A
CN115819494A CN202211743414.4A CN202211743414A CN115819494A CN 115819494 A CN115819494 A CN 115819494A CN 202211743414 A CN202211743414 A CN 202211743414A CN 115819494 A CN115819494 A CN 115819494A
Authority
CN
China
Prior art keywords
reaction
peg
additive
pegylation
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211743414.4A
Other languages
English (en)
Chinese (zh)
Inventor
M.R.希基
A.拉米雷斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CN115819494A publication Critical patent/CN115819494A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202211743414.4A 2015-11-23 2016-11-22 用于蛋白质聚乙二醇化的添加剂体系 Pending CN115819494A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562258644P 2015-11-23 2015-11-23
US62/258644 2015-11-23
PCT/US2016/063313 WO2017091568A1 (en) 2015-11-23 2016-11-22 Additive systems for use in protein pegylation
CN201680067897.7A CN108350025B (zh) 2015-11-23 2016-11-22 用于蛋白质聚乙二醇化的添加剂体系

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680067897.7A Division CN108350025B (zh) 2015-11-23 2016-11-22 用于蛋白质聚乙二醇化的添加剂体系

Publications (1)

Publication Number Publication Date
CN115819494A true CN115819494A (zh) 2023-03-21

Family

ID=57589163

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202211743414.4A Pending CN115819494A (zh) 2015-11-23 2016-11-22 用于蛋白质聚乙二醇化的添加剂体系
CN201680067897.7A Active CN108350025B (zh) 2015-11-23 2016-11-22 用于蛋白质聚乙二醇化的添加剂体系

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680067897.7A Active CN108350025B (zh) 2015-11-23 2016-11-22 用于蛋白质聚乙二醇化的添加剂体系

Country Status (17)

Country Link
US (3) US10617765B2 (https=)
EP (2) EP3789395B1 (https=)
JP (2) JP6921821B2 (https=)
KR (1) KR102688003B1 (https=)
CN (2) CN115819494A (https=)
CY (1) CY1123699T1 (https=)
DK (1) DK3380487T3 (https=)
ES (2) ES3055983T3 (https=)
HR (1) HRP20201832T1 (https=)
HU (1) HUE052634T2 (https=)
LT (1) LT3380487T (https=)
PL (1) PL3380487T3 (https=)
PT (1) PT3380487T (https=)
RS (1) RS61072B1 (https=)
SI (1) SI3380487T1 (https=)
SM (1) SMT202000649T1 (https=)
WO (1) WO2017091568A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3380487T (pt) * 2015-11-23 2020-10-29 Bristol Myers Squibb Co Sistemas de aditivos para utilização na peguilação de proteínas
HRP20240016T1 (hr) * 2018-09-11 2024-03-29 Ambrx, Inc. Konjugati polipeptida interleukina-2 i njihove uporabe
CN111484551B (zh) * 2020-03-19 2022-02-11 北京翼方生物科技有限责任公司 一种聚乙二醇修饰的重组人碱性成纤维细胞生长因子

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104710503A (zh) * 2005-11-08 2015-06-17 Ambrx公司 用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535571A1 (de) 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
TW518219B (en) 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
EP0885613A1 (de) 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US7329516B2 (en) * 2004-03-17 2008-02-12 Anticancer, Inc. Methods for increasing protein polyethylene glycol (PEG) conjugation
US20060286657A1 (en) * 2005-06-01 2006-12-21 Samuel Zalipsky Novel bioconjugation reactions for acylating polyethylene glycol reagents
CA2682147C (en) * 2007-03-30 2017-08-08 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
AU2014212308B2 (en) 2013-01-30 2018-08-09 Avelas Biosciences, Inc. Selective delivery molecules and methods of use
WO2014176284A1 (en) 2013-04-22 2014-10-30 Avelas Biosciences, Inc. Selective drug delivery compositions and methods of use
SMT202100388T1 (it) 2014-10-24 2021-09-14 Bristol Myers Squibb Co Polipeptidi fgf-21 modificati e loro usi
PT3380487T (pt) * 2015-11-23 2020-10-29 Bristol Myers Squibb Co Sistemas de aditivos para utilização na peguilação de proteínas

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104710503A (zh) * 2005-11-08 2015-06-17 Ambrx公司 用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PUBCHEM SID 24890836: "4-Aminobenzoic hydrazide, version3", pages 1, Retrieved from the Internet <URL:https://pubchem.ncbi.nlm.nih.gov/substance/24890836/version/3> *

Also Published As

Publication number Publication date
ES2827776T3 (es) 2021-05-24
EP3789395A1 (en) 2021-03-10
JP7257457B2 (ja) 2023-04-13
RS61072B1 (sr) 2020-12-31
PT3380487T (pt) 2020-10-29
US11213589B2 (en) 2022-01-04
SI3380487T1 (sl) 2020-11-30
HRP20201832T1 (hr) 2021-01-08
LT3380487T (lt) 2020-12-28
WO2017091568A1 (en) 2017-06-01
US20190351065A1 (en) 2019-11-21
CN108350025B (zh) 2023-02-21
US20220160883A1 (en) 2022-05-26
ES3055983T3 (en) 2026-02-17
WO2017091568A8 (en) 2018-01-04
EP3380487A1 (en) 2018-10-03
JP2019503994A (ja) 2019-02-14
PL3380487T3 (pl) 2020-12-28
HUE052634T2 (hu) 2021-05-28
EP3380487B1 (en) 2020-09-02
US20200276319A1 (en) 2020-09-03
CY1123699T1 (el) 2022-03-24
JP6921821B2 (ja) 2021-08-18
EP3789395B1 (en) 2025-08-27
US10617765B2 (en) 2020-04-14
JP2021176890A (ja) 2021-11-11
KR20180081610A (ko) 2018-07-16
SMT202000649T1 (it) 2021-01-05
CN108350025A (zh) 2018-07-31
KR102688003B1 (ko) 2024-07-23
DK3380487T3 (da) 2020-12-07

Similar Documents

Publication Publication Date Title
Kitov et al. Rapid, hydrolytically stable modification of aldehyde-terminated proteins and phage libraries
JP7257457B2 (ja) タンパク質のｐｅｇ化に用いるための添加物系
Sharley et al. Acetic acid as a catalyst for the N-acylation of amines using esters as the acyl source
Guthrie et al. Ketoxime peptide ligations: oxidative couplings of alkoxyamines to N-aryl peptides
US20160222054A1 (en) Ph switchable reagents and methods for their use
US8022173B2 (en) Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins
Byun et al. Preparation of polymer-bound pyrazolone active esters for combinatorial chemistry
Valeur et al. PS-IIDQ: an efficient polymer-supported amide coupling reagent
CN1329410C (zh) 使用具有催化性能的咪唑(如组氨酸)官能团催化剂稳定的过渡配合物进行酰基转移
Dou et al. Copper (II) Triflate‐Catalyzed Three‐Component Coupling of Aldehydes, Alkynes and Carbamates
CN108069868B (zh) 一种以芳基重氮四氟硼酸盐与腈制备有机酰胺类化合物的方法
Fu et al. Regioselective oxidative cleavage of conjugated dienes to access α, β-unsaturated nitriles
CN112209835B (zh) 一种制备对苯二胺的方法
Shao et al. A new polymer-bound N-hydroxysuccinimidyl active ester linker
KR101692992B1 (ko) 고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드
Manku et al. Synthesis and high performance liquid chromatography/electrospray mass spectrometry single-bead decoding of split-pool structural libraries of polyamines supported on polystyrene and polystyrene/ethylene glycol resins
CN109485580B (zh) 一种艾曲波帕中间体的合成方法
US20100145100A1 (en) Process for the preparation of amines
CN104262167B (zh) 一种二芳胺衍生物的制备方法
Islam Cyclization-Based Site-Selective N-Terminal Cysteine Conjugation, Peptide Stapling and Histone Deacetylase (HDAC) Probing
Boer The Development of Potent, Broad Spectrum Norbornane-based Antibacterial Agents
Sathyamoorthi et al. Adapting Bower’s Intramolecular Aziridination Reaction Allows for a Metal-Free Synthesis of N–H Aziridines
Monty Development of a Synthetic Toolkit for the Exploration of All-Hydrocarbon α-Helical Stapled Peptide Chemical Space via DNA-Encoded Chemical Libraries
HK40104266A (zh) 具有光开裂性部位的化合物、连结体和应用其的筛选方法
Méret Development of an efficient and flexible method for the solid-phase synthesis of N-hydroxypolyamine derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination